
Pharmacally
ADZYNMA
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in ADZYNMA
Drugs Safety AlertFDA Approves Boxed Warning for Adzynma Over Antibody RiskThe FDA has approved a Boxed Warning for Adzynma, highlighting the risk of neutralizing ADAMTS13 antibodies that can reduce treatment response and cause serious outcomes, including death.Fact-Checked
Drugs Safety AlertTakeda’s ADZYNMA Gets FDA Boxed Warning After Fatal Antibody CaseThe FDA has mandated a boxed warning for Takeda’s ADZYNMA following reports of neutralizing antibodies, including one fatal case in cTTP patients.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.